Background: Medical progress and the lifestyle modification have prolonged life expectancy, despite the development of...
Posté par : , Pr. Franck BONNETAIN
Nom de la revue : Trials
AbstractBackground: Frailty is highly prevalent in elderly people. While significant progress has been made to...
Posté par : Dr. Dewi VERNEREY, Dr. Sophie PAGET-BAILLY, , Pr. Franck BONNETAIN
Nom de la revue : BMC Geriatrics
AbstractBackground: Pancreatic adenocarcinoma (PDAC) incidence is increasing worldwide. Several studies have shown...
Posté par : Dr. Dewi VERNEREY, Pr. Franck BONNETAIN
Nom de la revue : BMC Cancer
Docetaxel, cisplatin, and 5-fluorouracil (DCF) significantly improved overall survival in metastatic gastroesophageal...
Posté par : Pr. Franck BONNETAIN, Dr. Sophie PAGET-BAILLY
Nom de la revue : Cancer Medecine
Measures of health-related quality of life (HRQOL) and other patient-reported outcomes generate important data...
Posté par : Pr. Franck BONNETAIN
Nom de la revue : Lancet Oncology
AbstractTemozolomide (TEM) showed encouraging results in well-differentiated pancreatic neuroendocrine tumors (WDPNETs)....
Posté par : Dr. Dewi VERNEREY
Nom de la revue : Endocrine-Related Cancer
AbstractThe diagnosis system for allograft loss lacks accurate individual risk stratification on the basis of...
Posté par : Dr. Dewi VERNEREY
Nom de la revue : J Am Soc Nephrol
In first-line metastatic colorectal cancer (mCRC), baseline prognostic factors allowing death risk and treatment...
Posté par : Dr. Dewi VERNEREY, Pr. Franck BONNETAIN
Nom de la revue : International Journal of Cancer
Background: The management of locally advanced pancreatic cancer (LAPC) patients remains controversial. Better...
Posté par : Dr. Dewi VERNEREY, , Pr. Franck BONNETAIN
Nom de la revue : British Journal of Cancer
Our aim was to review the studies which assessed potential surrogate endpoints for overall survival (OS) in breast...
Posté par : Pr. Franck BONNETAIN,
Nom de la revue : Breast
In the Intergroupe Francophone de Cancérologie Thoracique 0501 trial the carboplatinpaclitaxel chemotherapy increased...
Posté par : Pr. Franck BONNETAIN
Nom de la revue : European Respiratory Journal
Background: Even though the perioperative chemotherapy improves the overall survival (OS) compared to surgery alone in...
Posté par : Dr. Sophie PAGET-BAILLY, , Pr. Franck BONNETAIN
Nom de la revue : European Journal of Surgical Oncology
PurposeWe previously showed that a sequential chemotherapy with dose-dense oxaliplatin (FOLFOX7)and irinotecan (FOLFIRI;...
Posté par : Pr. Franck BONNETAIN
Nom de la revue : PLOS ONE
AbstractGlioblastoma is the most common malignant brain tumor in adults. Baselinehealth-relatedquality of life (HRQoL)...
Posté par : , Dr. Dewi VERNEREY, , Pr. Franck BONNETAIN
Nom de la revue : Cancer Medicine
OBJECTIVES: The objective of this study was to explore the association between health-related quality of life (HRQoL)...
Posté par : , Pr. Franck BONNETAIN
Nom de la revue : BMJ Open
09
May, 2016
OBJECTIVES: We conducted a prospective study approved by the local ethics committee to determine the impact of a...
Posté par : Pr. Franck BONNETAIN
Nom de la revue : Annales pharmaceutiques françaises
IMPORTANCE In locally advanced pancreatic cancer, the role of chemoradiotherapy is controversial and the efficacy of...
Posté par : Pr. Franck BONNETAIN
Nom de la revue : JAMA
Health-related quality of life (HRQOL) in cancer research is critical to more comprehensively evaluate patients’...
Posté par : Pr. Franck BONNETAIN, ,
Nom de la revue : Journal of Clinical Oncology
AbstractBackground: Health-related quality of life (HRQoL) is recognized as a component endpoint for cancer...
Posté par : Pr. Franck BONNETAIN
Nom de la revue : BMC Cancer